Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The host intestinal mucosal surface is a complex, multi-component barrier that separates the internal environment of the body from the external contents of the gut lumen. It is composed of a thick mucus layer, a specialized epithelial cell monolayer, and the underlying immune-rich lamina propria (Source: NIH, PubMed). This surface is essential for the selective absorption of nutrients and water while simultaneously preventing the translocation of pathogens and toxins into the systemic circulation. Dysfunction of this mucosal surface is a hallmark of several gastrointestinal disorders, including Crohn's disease and ulcerative colitis, where the breakdown of barrier integrity leads to chronic inflammation (Source: StatPearls). While not a single molecular target, it serves as a critical site for the action of locally delivered therapeutics, such as 5-aminosalicylates, and is the primary interface for oral vaccines and probiotic interventions (Source: Wikipedia, PubMed).
Local modulation of inflammatory pathways, physical protection of the epithelial layer, and stabilization of the mucosal barrier.
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Host intestinal mucosal surface.